论文部分内容阅读
目的:对细菌性肺炎的药物治疗进行经济学研究。方法:通过对112例无其它基础疾病、经住院治疗、治愈出院的细菌性肺炎患者进行用药及费用的调查。结果:112例患者选用抗菌药近40种,治疗方案组合超过100种,药费及治疗费占总住院费用66％。结论:细菌性肺炎的药费及治疗费对医疗成本高低起着决定性作用。应对该类疾病的药物选用,有计划地进行前瞻性药物经济学成本-效果分析研究,以确保卫生资源的合理使用。
Objective: To study the economics of drug treatment of bacterial pneumonia. Methods: 112 patients with no other underlying diseases, hospitalized, cured patients with bacterial pneumonia were investigated for cost and medication. Results: Of the 112 patients, nearly 40 kinds of antibacterials were used, more than 100 combinations of treatment regimens and 66% of total hospitalization expenses were spent on medicine and treatment. Conclusion: Bacterial pneumonia drug costs and treatment costs play a decisive role in the level of medical costs. The selection of drugs for such diseases should be carried out in a planned and prospective cost-effectiveness analysis of pharmaceutical economics to ensure the rational use of health resources.